Holt RIG, et al. The management of type 1 diabetes in adults. A consensus report by the american diabetes association (ADA) and the european association for the study of diabetes (EASD). Diabetes Care. 2021;44(11):2589–625. https://doi.org/10.2337/dci21-0043.

Article  CAS  PubMed  Google Scholar 

Magliano DJ, Boyko EJ. IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS [Internet]. 10th ed. Brussels: International Diabetes Federation; 2021.

Nathan DM, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86. https://doi.org/10.1056/NEJM199309303291401.

Article  CAS  PubMed  Google Scholar 

Calderon Martinez E, et al. Insulin Pump Therapy vs Multiple Daily Insulin Injections for Glycemic Control in Children With Type 1 Diabetes: A Systematic Review and Meta-Analysis. Cureus. 2024;16(1):e52054. https://doi.org/10.7759/cureus.52054.

Article  PubMed  PubMed Central  Google Scholar 

Criego AB, et al. Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2024;26(1):11–23. https://doi.org/10.1089/dia.2023.0364.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown SA, et al. Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes. Diabetes Care. 2021;44(7):1630–40. https://doi.org/10.2337/dc21-0172.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Molfetta S, et al. Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis. Diabetes Metab Res Rev. 2024;40(6):e3842. https://doi.org/10.1002/dmrr.3842.

Article  PubMed  Google Scholar 

M. Cumpston et al “Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions”. Cochrane Database Syst Rev. 2019 ; 10 10, ED000142. https://doi.org/10.1002/14651858.ED000142

Page MJ, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. https://doi.org/10.1016/j.ijsu.2021.105906.

Article  PubMed  Google Scholar 

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https://doi.org/10.1186/s13643-016-0384-4.

Article  PubMed  PubMed Central  Google Scholar 

Lo CK-L, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14:45. https://doi.org/10.1186/1471-2288-14-45.

Article  PubMed  PubMed Central  Google Scholar 

Sterne JAC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https://doi.org/10.1136/bmj.i4919.

Article  PubMed  PubMed Central  Google Scholar 

Buckingham BA, et al. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm. Diabetes Technol Ther. 2018;20(4):257–62. https://doi.org/10.1089/dia.2017.0346.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buckingham BA, et al. Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2018;20(9):585–95. https://doi.org/10.1089/dia.2018.0138.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forlenza GP, et al. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2019;21(5):265–72. https://doi.org/10.1089/dia.2019.0017.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sherr JL, et al. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technol Ther. 2020;22(3):174–84. https://doi.org/10.1089/dia.2019.0286.

Article  PubMed  PubMed Central  Google Scholar 

Sherr JL, et al. Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial. Diabetes Care. 2022;45(8):1907–10. https://doi.org/10.2337/dc21-2359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forlenza GP, et al. Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes Technol Ther. 2024;26(8):514–25. https://doi.org/10.1089/dia.2023.0578.

Article  PubMed  Google Scholar 

Aslam A, et al. Real-world data from first UK Omnipod 5 users: A single-centre observational study. Diabetes Obes Metab. 2024;26(8):3462–5. https://doi.org/10.1111/dom.15629.

Article  PubMed  Google Scholar 

Marks BE, et al. Real-World Glycemic Outcomes with Early Omnipod 5 Use in Youth with Type 1 Diabetes. Diabetes Technol Ther. 2023;25(11):782–9. https://doi.org/10.1089/dia.2023.0337.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Renard E et al “Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical Trial”. Diabetes Care. 2024. https://doi.org/10.2337/dc24-1550.

Polonsky WH, et al. How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System. Diabetes Res Clin Pract. 2022;190:109998. https://doi.org/10.1016/j.diabres.2022.109998.

Article  PubMed  PubMed Central  Google Scholar 

Hood KK, et al. Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers. Pediatr Diabetes. 2023;2023:1–12. https://doi.org/10.1155/2023/8867625.

Article  Google Scholar 

Folk S, Zappe J, Wyne K, and Dungan KM “Comparative Effectiveness of Hybrid Closed-Loop Automated Insulin Delivery Systems Among Patients with Type 1 Diabetes”. J Diabetes Sci Technol. 2024; 19322968241234948 https://doi.org/10.1177/19322968241234948

Stimson RH, et al. Outcomes after 1 year in adults using Omnipod 5: Real-world data from aUK diabetes centre. Diabet Med. 2024;41:12. https://doi.org/10.1111/dme.15453.

Article  Google Scholar 

Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–9. https://doi.org/10.1126/science.abe9985.

Article  CAS  PubMed  PubMed Central  Google Scholar